Skip to content
Wishlist0 Cart 0

For research use only. Not for human or veterinary use. Product information is provided for laboratory research reference.

Retatrutide 20mg research peptide vial
  • 99.516% purity
  • Independently tested
  • Research use only

Retatrutide

Triple-agonist research peptide supplied as a lyophilised powder for laboratory investigation of GIP, GLP-1 and glucagon receptor activity.

Strength
$180.00
CoAView certificate of analysis
Description

Retatrutide (LY3437943) is a synthetic 39-amino-acid peptide designed to act on three receptors at once: GIP, GLP-1 and glucagon. This triple-agonist profile makes it a key reference compound in metabolic and incretin research.

Research focus

  • GIP, GLP-1 and glucagon receptor signalling
  • Energy balance and metabolic pathway research
  • Comparative studies alongside dual and single agonists such as tirzepatide

Supplied as a lyophilised powder in a sealed vial. Available in 10 mg, 20 mg and 30 mg.

Each batch is independently tested, and the certificate of analysis matching the lot number on your vial is published on our COA page.

For laboratory research use only. Not for human or veterinary use.

  • Same-day dispatch on business days Order before 2:00 pm AEDT on business days
  • Free express shipping over $150 Tracked delivery Australia-wide
  • Protected, discreet packaging Every vial cushioned and sealed
  • Certificate for every batch Lot-matched, independently tested
Secure, encrypted checkout

Verified test results

Every batch, independently verified.

Each batch is tested by an independent laboratory before it ships. This is the report for the current batch.

JanoshikThird-party analysis

Certificate of analysis

99.516%

Purity by HPLC

Lot
#215548
Tested
17 Aug 2026
Labelled
20mg
Measured
22.15mg
View signed certificate (PDF)

Quality panel 3 assays passed

  • Peptide purityNot specified 99.516%Pass
  • IdentityLC-MS Not explicitly confirmedPass
  • Net peptide content22.15mg ReportedPass

Every batch on record

Open any lot’s certificate. Your order ships from a documented batch with its own lot-specific report.

  • Retatrutide 30mg Latest

    Lot #230343

    99.831%HPLC purity · meets spec

    Labelled
    30mg
    Measured
    33.16mg
    Identity
    Not explicitly confirmed
    Tested
    14 Sep 2026

    3 assays passed · Janoshik

    View certificate — Retatrutide 30mg, #230343

  • Retatrutide 10mg Selected strength

    Lot #215484

    99.682%HPLC purity · meets spec

    Labelled
    10mg
    Measured
    10.68mg
    Identity
    Not explicitly confirmed
    Tested
    17 Aug 2026

    3 assays passed · Janoshik

    View certificate — Retatrutide 10mg, #215484

  • Retatrutide 20mg Selected strength

    Lot #215548

    99.516%HPLC purity · meets spec

    Labelled
    20mg
    Measured
    22.15mg
    Identity
    Not explicitly confirmed
    Tested
    17 Aug 2026

    3 assays passed · Janoshik

    View certificate — Retatrutide 20mg, #215548

Technical specifications

Compound information

Molecular profile

What is Retatrutide?

Retatrutide (LY3437943) is a synthetic 39-amino-acid peptide designed to act on three receptors at once: GIP, GLP-1 and glucagon. This triple-agonist profile makes it a key reference compound in metabolic and incretin research.

Research focus

  • GIP, GLP-1 and glucagon receptor signalling
  • Energy balance and metabolic pathway research
  • Comparative studies alongside dual and single agonists such as tirzepatide

Supplied as a lyophilised powder in a sealed vial. Available in 10 mg, 20 mg and 30 mg.

Each batch is independently tested, and the certificate of analysis matching the lot number on your vial is published on our COA page.

For laboratory research use only. Not for human or veterinary use.

Type
Synthetic peptide (GIP/GLP-1/glucagon receptor agonist)
CAS number
2381089-83-2
Molecular weight
4,731 g/mol
Amino acids
39
Fatty acid chain
C20 diacid

Storage requirements

Stability information

  • Lyophilised (sealed vial)−20 °C long-term, protected from light
  • Reconstituted2–8 °C, use within 28 days
  • In transitStable at ambient temperature for shipping

Product details

Strength
10mg, 20mg, 30mg
Purity
≥99% (HPLC)
Form
Lyophilised powder
Current lot
#215548

You may also need

All the research compounds you need, with the documentation and supply you can rely on.

Order now